The Uganda National HIV viral load suppression prevalence of
59.6% is below the 95% target. The study conducted
in in four health facilities of Jinja district, on 437 files of adult HIV clients with; missed appointments
of more than two weeks, poor adherence to treatment of < 85%, and unsuppressed
viral load of > 1000 viral copies per milliliter, between January and
July 2019, was aimed at determining
change packages to improve HIV care in the study health facilities. Data was analyzed
using Microsoft excel and the following tested changes using the Deming
PDSA cycles were used; Intensified health education, and adherence counseling to
all patients with poor adherence, pill counting to harmonize the pills supplied
with the appointment date, follow up phone calls to patients who miss appointment,
creation of a one stop centre for HIV care, and increased staffing of HIV clinic.
Study results showed a 13.6% prevalence of the study HIV care poor outcomes at baseline
assessment. 11.8%, 65.2%, and 46.5% of the study client files
were due to poor adherence to treatment, two weeks
missed appointments, and unsuppressed viral load respectively at baseline
assessment and 4.7%, 25.1%, and 31.5% respectively
at end line assessment. 80% of the studied clients were retention in care between
baseline and end line assessments. In conclusion, there was a positive effect on the patient HIV care out
Keywords: Adherence to treatment, appointment keeping, and viral suppression
in HIV care.
WHO, (2013). Consolidated
guidelines on the use of antiretroviral drugs for treating and preventing HIV infection:
recommendations for a public health approach. Geneva Switzerland: World Health Organization;
2013. http:// apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf.
. MoH (2016) a. Consolidated guidelines for HIV prevention,
and treatment in Uganda 2016.
. Cohen MS, Chen YQ, McCauley M, et al (2011).; HPTN 052
Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl
J Med 2011; 365:493–505.
ECASA Group of Consultants
LTD, (2018). Uganda AIDS Country Progress Report July 2017-June 2018.
Kolab Chhim1, Gitau
Mburu2, Sovannary Tuot1, Ratana Sopha1, Vohith Khol3, Pheak Chhoun1 and Siyan (2018).
Factors associated with viral non‑suppression among
adolescents living with HIV in Cambodia: a cross‑sectional study.
AIDS Research and Therapy. 15:20. https://doi.org/10.1186/s12981-018-0205-z.
Virus Research Institute (2018). National HIV Drug Resistance Prevention, Monitoring
and Surveillance Activities, National Status Report 2018.
Kranzer, Stephen D. Lawn, Leigh F. Johnson, Linda-Gail Bekker, and Robin Wood, (2014).
Community viral load and CD4 count distribution among people living with HIV in
a South African township: implications for treatment as prevention. Europe PMC Funders
Group. J Acquir Immune Defic Syndr. 2013 August 1; 63(4): 498–505. doi:10.1097/QAI.0b013e318293ae48.
. Bonner K, et al. Viral load monitoring as a tool to reinforce
adherence: a systematic review. J Acquir Immune Defic Syndr. 2013;64(1):74–8.
. Nasuuna Esther, Joanita Kigozi1, Lillian Babirye, Alex
Muganzi, Nelson K. Sewankambo and Damalie Nakanjako, (2018). Low HIV viral suppression
rates following the intensive adherence counseling (IAC) program for children and
adolescents with viral failure in public health facilities in Uganda. Nasuuna et
al. BMC Public Health (2018) 18:1048. https://doi.org/10.1186/s12889-018-5964-x
C., Beery M, Carmichael B, Skosana C, Pahad S, Buthelezi B, Delany-Moretlwe S, Imrie
J, (2018). Reaching 90-90-90 targets amongst adolescents and young people in South
Africa: A model of integrated adolescent care. 12th International Workshop on HIV
Treatment, Pathogenesis, and Prevention Research in Resource-limited Settings; 29
May – 1 June 2018, Kigali, Rwanda.
. Garcı´a de Olalla P, Knobel H, Carmona A, Guelar A, Lo´pezColome´s
JL, Cayla` JA (2002). Impact of adherence and highly active antiretroviral therapy
on survival in HIV-infected patients. J Acquir Immune DeficSyndr 2002; 30: 10510.
. MoH (2016) b. National STD/AIDS Control Program, Viral
Load Monitoring Training Facilitator’s
. Chalker JC, Andualem T, Gitau LN, Ntaganira J, Obua C,
Tadeg H, et al (2010). Measuring adherence to antiretroviral treatment in resource-poor
settings: the feasibility of collecting routine data for key indicators. BMC Health
Serv Res 2010; 10: 43.
. Gusdal AK, Obua C, Andualem T, Wahlstrom R, Tomson G, Peterson
S, et al (2009). Voices on adherence to ART in Ethiopia and Uganda: a matter of
choice or simply not an option? AIDS Care 2009; 21: 13817.
. Carly Hudelson& Lucie Cluver (2015). Factors associated
with adherence to antiretroviral therapy among adolescents living with HIV/AIDS
in low- and middle-income countries: a systematic review, AIDS Care: Psychological
and Socio-medical Aspects of AIDS/HIV, 27:7, 805-816, DOI: 10.1080/09540121.2015.1011073
. Bharatesh D. Basti,1 Venkatesha Mahesh,2 Dattatreya
D. Bant,3 and Geeta V. Bathija (2017). Factors affecting antiretroviral treatment adherence among people living
with human immunodeficiency virus/acquired immunodeficiency syndrome: A prospective
study. Journal of family medicine and primary care.
Oku O. Afiong, Eme
T. Owoaje, Oboko O. Oku and Emmanuel Monjok (2014). Prevalence and Determinants
of Adherence to Highly Active Anti-Retroviral Therapy Amongst People Living with
HIV/AIDS in a Rural Setting in South-South Nigeria. African Journal of Reproductive
Health March 2014; 18(1): 134
Horstmann, Jillian Brown, Fareesa Islam, Johanna Buck, and Bruce D. Agins, (2010).
Retaining HIV-Infected Patients in Care: Where Are We? Where Do We Go from Here?
Clinical Infectious Diseases 2010; 50:752–761
Park WB, Choe PG,
Kim SH, Jo JH, Bang JH, Kim HB, Kim NJ, Oh M, Choe KW: One-year adherence to clinic
visits after highly active antiretroviral therapy: a predictor of clinical progress
in HIV patients. J Intern Med 2007, 261(3):268–275.
. Smith E. O., J. D. Curb, and R. J. Hardy, “Clinic attendance
in the hypertension detection and follow-up program,” Hypertension, vol. 4, no.
5, pp. 710–715, 1982. View at Google Scholar · View at Scopus
Nemes MI, Carvalho
HB, Souza MF, (2004). Antiretroviral therapy adherence in Brazil. AIDS. https://www.ncbi.nlm.nih.gov/pubmed/15322479.
GM, Chaisson RE, Moore RD, (1999). Highly active antiretroviral therapy in a large
urban clinic: risk factors for virologic failure and adverse drug reactions. Ann
Intern Med; 131(2):81–87.
TenoRes Study Group (2016). Global epidemiology of drug resistance
after failure of WHO recommended first-line regimens for adult HIV-1 infection:
a multicentre retrospective cohort study. Lancet Infect Dis. 2016 May;16(5):565-575.
Sethi A, Celentano
D, Gange S, Moore R, Gallant J. Association between adherence to antiretroviral
therapy and human immunodeficiency virus drug resistance. Clin Infect Dis 2003;
Gupta RK, Gregson J, Parkin N, Haile-Selassie H, Tanuri A, Andrade
Forero L, Kaleebu P, Watera C, Aghokeng A, Mutenda N, Dzangare J, Hone S, Hang ZZ,
Garcia J, Garcia Z, Marchorro P, Beteta E, Giron A, Hamers R, Inzaule S, Frenkel
LM, Chung MH, de Oliveira T, Pillay D, Naidoo K, Kharsany A, Kugathasan R, Cutino
T, Hunt G, Avila Rios S, Doherty M, Jordan MR, Bertagnolio S. HIV-1 drug resistance
before initiation or re-initiation of first-line antiretroviral therapy in low-income
and middle-income countries: a systematic review and meta-regression analysis. Lancet
Infect Dis. 2018 Mar;18(3):346-355.
. Moore CG, Wilson-Witherspoon P, Probst JC, (2001). Time
and money: effects of no-shows at a family practice residency clinic. Fam Med 2001;
. Shumba c., L. Atuhaire, R. Imakit, R.
Atukunda, and P. Memiah. Missed Doses and Missed Appointments: Adherence to ART
among Adult Patients in Uganda. Hindawi Publishing Corporation, ISRN AIDS, Volume 2013, Article
ID 270914, 7 pages, http://dx.doi.org/10.1155/2013/270914
Bigna Jean Joel R,
Jean Jacques N Noubiap, Claudia S Plottel, Charles Kouanfack1, and Sinata Koulla-Shiro,
(2014). Factors associated with non-adherence to scheduled medical follow-up appointments
among Cameroonian children requiring HIV care: a case-control analysis of the usual-care
group in the MORE CARE trial.
. Setor Kunutsor,1 John Walley,1 Elly Katabira,2 Simon Muchuro,2
Hudson Balidawa,3 Elizabeth Namagala,3 and Eric Ikoona3, (2010). Clinic Attendance
for Medication Refills and Medication Adherence amongst an Antiretroviral Treatment
Cohort in Uganda: A Prospective Study. Hindawi Publishing Corporation AIDS Research
and Treatment Volume 2010, Article ID 872396, 8 pages doi:10.1155/2010/872396.